Sign In

Login

Password

Forgot Password ? Sign Up

דנוסומאב (Hebrew Wikipedia)

Analysis of information sources in references of the Wikipedia article "דנוסומאב" in Hebrew language version.

refsWebsite
Global rank Hebrew rank
10nih.gov
4th place
18th place
2amgen.com
low place
low place
1tandfonline.com
507th place
244th place
1europa.eu
68th place
170th place
1drugs.com
399th place
650th place
1todaysgeriatricmedicine.com
low place
low place
1nytimes.com
7th place
32nd place
1medpagetoday.com
9,274th place
3,129th place
1boston.com
310th place
546th place
1genengnews.com
low place
low place
1cancer.gov
1,684th place
1,081st place

amgen.com

boston.com

archive.boston.com

cancer.gov

drugs.com

europa.eu

ema.europa.eu

  • European Medicines Agency Prolia

genengnews.com

medpagetoday.com

nih.gov

ncbi.nlm.nih.gov

  • McClung, Michael R.; Lewiecki, E. Michael; Cohen, Stanley B.; Bolognese, Michael A.; Woodson, Grattan C.; Moffett, Alfred H.; Peacock, Munro; Miller, Paul D.; et al. (2006). "Denosumab in Postmenopausal Women with Low Bone Mineral Density". N Engl J Med. 354 (8): 821–31. doi:10.1056/NEJMoa044459. PMID 16495394.
  • Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C; FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009 Aug 20;361(8):756-65. doi:10.1056/NEJMoa0809493. PMID 19671655.
  • Lipton, A; Fizazi, K; Stopeck, AT; Henry, DH; Brown, JE; Yardley, DA; Richardson, GE; Siena, S; Maroto, P; Clemens, M; Bilynskyy, B; Charu, V; Beuzeboc, P; Rader, M; Viniegra, M; Saad, F; Ke, C; Braun, A; Jun, S (November 2012). "Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials". EJC (Oxford, England : 1990). 48 (16): 3082–92. doi:10.1016/j.ejca.2012.08.002. PMID 22975218.
  • Zhou Z, Chen C, Zhang J, Ji X, Liu L, Zhang G, Cao X, Wang P. Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis. Int J Clin Exp Pathol. 2014 Apr 15;7(5):2113-22. PMID 24966919; https://pubmed.ncbi.nlm.nih.gov/24966919/
  • Sundeep Khosla Increasing Options for the Treatment of Osteoporosis
  • TNFSF11 TNF superfamily member 11 Homo sapiens (human)
  • Alison M Boyce Denosumab: An Emerging Therapy in Pediatric Bone Disorders

pubmed.ncbi.nlm.nih.gov

  • Bone HG, Wagman RB, Brandi ML, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and openlabel extension. Lancet Diabetes Endocrinol. 2017; 5:513-523. https://pubmed.ncbi.nlm.nih.gov/28546097/
  • Zhou Z, Chen C, Zhang J, Ji X, Liu L, Zhang G, Cao X, Wang P. Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis. Int J Clin Exp Pathol. 2014 Apr 15;7(5):2113-22. PMID 24966919; https://pubmed.ncbi.nlm.nih.gov/24966919/
  • Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB. American Association Of Clinical Endocrinologists/American College Of Endocrinology Clinical Practice Guidelines For The Diagnosis And Treatment Of Postmenopausal Osteoporosis - 2020 Update Executive Summary. Endocr Pract. 2020 May;26(5):564-570. https://pubmed.ncbi.nlm.nih.gov/32427525/

nytimes.com

tandfonline.com

todaysgeriatricmedicine.com